RxDoctor Payments DataLook up a doctor →

Adam Maass

Endocrinology, Diabetes & Metabolism · Springdale, ARNPI 1841258738

Payments from drug & device makers

$502,367in general payments, 2019–2025

Across 1,065 payments — averaging $471.71 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Lilly USA, LLC$304K
  • Novo Nordisk$115K
  • Boehringer Ingelheim$26K
  • Chiasma, Inc.$14K
  • AbbVie$13K
  • Dexcom, Inc.$12K
  • plus $19K from 25 others

General payments by program year

19
20
21
22

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$502,367 in reported general payments places this provider in the 90th percentile of 43 endocrinology, diabetes & metabolism providers in Arkansas.

See all endocrinology, diabetes & metabolism providers in Arkansas

Other endocrinology, diabetes & metabolism in Springdale

See the full list for Arkansas

Where these figures come from

Is this you, or does something look wrong? →